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(COM/2015/S2) 
 
COMMITTEE ON MUTAGENICITY OF CHEMICALS IN FOOD, CONSUMER 
PRODUCTS AND THE ENVIRONMENT 
 
Statement on the mutagenicity of alcohol (ethanol) and its metabolite 
acetaldehyde: update on information published between 2000-2014  
 
Background 
 
1. In 1995, the COM provided a statement on the mutagenicity of alcoholic 
beverages (COM, 1995) for the Interdepartmental Working Group 1995 Report on 
Sensible Drinking (Department of Health, 1995). At that time, the Committee 
concluded that the consumption of alcoholic beverages was of no concern in relation 
to their mutagenic potential. In 2000, the Committee on Carcinogenicity (COC) 
requested an update of the COM’s 1995 opinion, following the COC’s statement in 
2000 on alcohol consumption and breast cancer; there being reported evidence of a 
possible association and hypotheses proposed on the potential etiological role of 
reactive oxygen species (ROS) (COC, 2000). The COM evaluated studies published 
between 1995 and 2000 to update their review (COM, 2000a) and concluded that 
there was insufficient evidence to support the hypothesis that alcohol induces breast 
cancer via the formation of ROS. The COM also reaffirmed its previous conclusion 
with respect to the lack of concern regarding the mutagenic potential of alcoholic 
beverages (COM, 2000b).  
 
2. In 2013, the Committee on Carcinogenicity started to reassess the 
relationship between alcohol consumption and cancer, and requested a further 
update of the COM opinion, to provide insight into potential mechanisms.  
 
3. This statement details the conclusions reached by the COM with regard to the 
published evidence on the genotoxicity and mutagenicity of ethanol, acetaldehyde 
and alcoholic beverages from January 2000 to May 2014, including the modifications 
made to the conclusions drawn in 2000.  
 
4. A discussion of the role of reactive oxygen species and other metabolites in 
the genotoxicity and mutagenicity of alcohol is also included.  
 
 
 
 
 
 
 
Mutagenicity of ethanol  
 
5. The Committee noted that seven new in vitro genotoxicity studies on ethanol 
have been published since January 2000, mostly in human cell lines and also 
primary cells collected from humans or rats. Effects suggestive of genotoxicity were 
generally reported, however, the Committee were unable to draw any clear 
conclusions due to the poor quality or relevance of the evidence. The 4-fold increase 
in levels of DNA strand breaks detected in primary human gastric mucosa cells was 
associated with exposure to a very high concentration of ethanol (1M) that would 
most likely cause secondary effects such as irritation, dehydration and cell tissue 
damage (Blasiak et al., 2000). The Committee felt that the damage caused to the 
genome from such effects would be difficult to distinguish from any primary effects 
that ethanol might have.  
 
6. Although three of the studies observed statistically significant increases in 
genotoxic endpoints in cells exposed to ethanol at concentrations within a range 
realistically achievable in alcohol drinkers, no clear conclusions could be reached 
(Lamarche et al., 2003, Benassi-Evans & Fenech., 2011, Kayani & Parry., 2010). 
DNA strand breaks in acutely exposed primary rat astrocytes were associated with 
only a very marginal increase in the percentage of DNA in Comet tails of exposed 
cells (Lamarche et al., 2003) or no effect (Signorini-Allibe et al 2005). Chromosome 
damage and genome instability observed in a human lymphoblast cell line (WIL2-
NS) could not be attributed with confidence to a proposed aneugenic effect of 
ethanol in the absence of any studies to rule out acetaldehyde as the causative 
agent (Benassi-Evans & Fenech., 2011).  
 
7. Members agreed that Kayani & Parry (2010) provided an interesting 
observation that the induction of micronuclei (MN) by ethanol appeared to be by an 
aneugenic mechanism. Members suggested that the increase in kinetochore positive 
(K+) MN in ethanol treated cells might also be explained by: (i) spindle damage via 
an oxidative effect (although, it was noted that in vivo studies provide evidence that 
contradicts such a direct acting MOA); (ii) an artefact due to the acetaldehyde-
protein cross-links which may disrupt the kinetochore protein leading to a false 
kinetochore negative (K-) responses. Members felt the data were difficult to 
rationalise, but the findings could not be ignored. Further investigations would be 
required before definitive conclusions could be drawn by the Committee.  
 
8. A number of new in vivo studies were available in which DNA adduction, and 
the formation of MN, chromosome aberrations (CAs) and DSBs, had been 
investigated in rodents exposed to ethanol orally at concentrations of up to 20% v/v 
in the drinking water. The Committee found that the studies evaluating genotoxic 
endpoints were unclear, and yielded mixed results that made them difficult to 
interpret. A study investigating MN in rats chronically exposed to 0 to 15% v/v 
ethanol (Ellahueñe et al., 2012) found no alcohol-induced increase in MN frequency. 
This contrasted with the findings of two other studies in rodents exposed 
subchronically to 10% ethanol, in which there were increases in MN (Kotova et al., 
2013; Cebral et al., 2011). Inconsistent results were also obtained in studies of the 
types of acetaldehyde-specific DNA adducts detected in the liver and stomach of 
aldehyde dehydrogenase-type 2 knockout mice chronically exposed to 20% ethanol 
v/v (Matsuda et al., 2007; Nagayoshi et al., 2009). N2-ethylidene-dG adduct levels 
were increased by up to 40-fold in ALDH2-knockout mice compared with untreated 
wild-type mice, whereas no N2-ethyl-dG or α-Me-γ-OH-PdG adducts could be 
detected in either strain.  
 
9. Members emphasised the importance of considering the capacity of a tissue 
to metabolise ethanol via the microsomal cytochrome P450 2E1 (CYP2E1) mono-
oxygenase pathway in light of growing evidence of the involvement of this enzyme in 
the genotoxicity of alcohol from experiments conducted in animals (and in vitro) 
(Seitz and Stickel 2006; Linhart et al 2014).  
 
10. Members considered that the in vivo studies evaluating effects of ethanol in 
germ cells did not provide any data of relevance to its mutagenicity (Cebral et al., 
2011; Talebi et al 2011; Ellahueñe et al., 2012; Rahimipour et al 2013). 
 
11. The Committee updates its previous conclusion with regard to the 
mutagenicity data on ethanol: namely that although some new in vitro studies 
reported evidence of genotoxicity, the mixed findings from animal experiments in 
vivo and the poor quality of the studies for ethanol in general, prevent any definite 
conclusions from being drawn.  
 
 
Mutagenicity of acetaldehyde  
 
12. Acetaldehyde is widely accepted as being genotoxic in vitro and in vivo, when 
administered directly. However, there is uncertainty whether such effects occur when 
it is produced in vivo following metabolism of ethanol.  
 
13. The Committee agreed that the recent in vitro data on acetaldehyde added 
further strong evidence for the genotoxicity of this compound. These studies, 
described below, all reported that acute exposure of human and mammalian cells 
resulted in the induction of MN, sister chromatid exchanges (SCEs), and DNA strand 
breaks (DSBs). However, as documented in previous statements, many of these 
effects were observed only with high concentrations of acetaldehyde, well above 
those that would be experienced in human saliva, blood or tissues after drinking 
alcohol.   
 
14. Members noted a  number of studies that have helped characterise some of 
the key lesions thought to play a role in the mutagenicity of acetaldehyde; namely 
interstrand DNA cross-links (Blasiak et al., 2000), 1,N2-propano-dG or PdG (Wang et 
al., 2000, Sako et al., 2003), and N2-ethylidene-dG (Hori et al., 2012), albeit using 
very high concentrations of acetaldehyde. Studies conducted in bacterial and in 
human cell lines transfected with either synthetically-derived N2-ethyl-dG or PdG 
adducts (Stein et al., 2006; Upton et al., 2006;) or exposed to high levels of 
acetaldehyde (Noori & Hou., 2001) suggested guanine nucleotides were the primary 
targets for point mutations, particularly G to T transversions.   
 
15. Concentration-dependent increases in PdG adducts were observed in a study 
in which pig liver DNA was exposed directly to acetaldehyde at a concentration 
range realistically achievable in saliva (Theruvathu et al., 2005). Detectable amounts 
of PdG adducts were formed in the presence of polyamines at concentrations as low 
as 100µM acetaldehyde. Mammalian cells exposed to biologically relevant 
concentrations of acetaldehyde also exhibited concentration-dependent increases in 
MN (Kayani & Parry., 2010; Speit et al., 2008), SCEs (Speit et al., 2008) and DSBs 
(Signorini-Allibe et al., 2005).  
  
16. The Committee considered the suggestion that acetaldehyde induction of MN 
is via a clastogenic mechanism (Kayani & Parry, 2010). Members felt that despite 
the concentration-dependent increase in kinetochore negative (K-) cells and the 
decrease in kinetochore positive (K+) cells there was no evidence of acentric 
fragments. However this may not represent a clastogenic response because 
acetaldehyde is thought to interact with kinetochore proteins, due to the artefactual 
binding described previously (see paragraph 7). The Committee suggested the 
proposed clastogenic effect to be plausible, until there was evidence to the contrary. 
 
17. Members considered Kotova et al (2013) to be a very sound study, which 
provided a plausible hypothesis for the mechanism of induction of MN by 
acetaldehyde: namely via formation of replication-associated DSBs in dividing cells. 
However, given that this was just one study in cells exposed to very high 
concentrations of acetaldehyde, further investigation would be required before 
conclusions could be reached by the Committee.   
 
18. A single study evaluated the possible in vivo genotoxicity of acetaldehyde 
(Torres-Bezauri et al., 2002). The implications of the observed dose-dependent 
increase in levels of SCEs in treated mice were limited by the choice of route of 
exposure (intraperitoneal) and the use of unrealistically high doses of acetaldehyde.  
 
19. The Committee updates its previous conclusion and notes that the weight of 
evidence for the in vitro mutagenicity of acetaldehyde has been further strengthened, 
particularly with regard to generation of specific DNA adducts and induction of MN in 
mammalian cells at concentrations of acetaldehyde realistically achievable from 
alcoholic beverage consumption.  
 
 
Mutagenicity of alcoholic beverages 
 
20. The Committee noted a number of recent studies investigating genotoxic and 
mutagenic effects arising from the consumption of alcoholic beverages in humans. 
No new studies were identified in experimental animals or in vitro. A potential for 
publication bias was highlighted by the fact that the majority of studies reported 
positive findings for all of the mutagenic and genotoxic endpoints assessed.  
 
21. Members considered the extent of exposure to sources of ethanol other than 
from alcoholic beverage consumption, and to other alcohols including the lower 
volatile alcohols such as propanol and methanol.  The Committee considered that 
with the exception of sanitizers, mouthwashes, and personal care products, 
exposure to these alcohols generally occurs from endogenous production 
(production by gut bacteria, and the fermentation of yeast and fruit) or from the diet, 
and only in minute quantities compared with the consumption of alcoholic beverages.  
Members were informed that these additional sources are not being considered by 
the COC. Members agreed that there is no evidence to suggest that exposure to 
these additional sources of ethanol/alcohols would significantly increase the 
frequency of genotoxic events above background levels in non-drinking individuals.  
 
22. In one study, no change in basal levels of the N2-ethylidene-deoxyguanosine 
(N2-ethyl-dG) adduct were observed in peripheral blood white cells taken from 
healthy non-smoking Polish volunteers, 48h after exposure to 150ml of vodka in an 
experimental setting (Singh et al., 2012). This contrasted with the dose-dependent 
increase in adduct levels observed in peripheral blood white cells and oral epithelial 
cells of healthy non-smoking US University students/staff who achieved up to 0.07% 
blood alcohol concentrations within three weeks under controlled exposure 
conditions (Balbo et al., 2012a,2012b). Exposure to alcohol increased adduct levels 
in oral epithelial cells by up to 15-fold compared with background levels. However, 
substantial intra-individual variation in baseline adduct levels was apparent in both 
studies.  The US study did not account for body weight index (BMI), a known 
carcinogenic risk factor, and furthermore, the human DNA obtained from mouthwash 
samples was potentially contaminated with bacterial DNA. Members advised caution 
in interpreting the results of studies of DNA adduction due to the different 
approaches used in the studies. For example, different sensitivities of the study 
methods, duration of exposure and account for confounding factors affecting 
background adduct levels (e.g. BMI, diet or nutritional status) 
 
23. Members considered that the N2-ethyl-dG adduct was a good biomarker of 
acetaldehyde exposure, although its specificity for ethanol exposure was questioned 
given that the adduct is also generated endogenously (present in normal animal and 
human liver DNA at levels in the range of 0.1 lesion/106 normal nucleotides (IARC 
2010). Exposure to acetaldehyde also arises from endogenous processes, and can 
occur through diet/lifestyle and occupation.  
 
24. Few of the observational investigations reviewed had stratified drinking 
categories into levels that would enable evaluation of a quantitative dose-response 
relationship. The changes observed in mutagenic endpoints assessed in studies that 
provided two or more drinking categories either were not dose-dependent (Ishikawa 
et al., 2007, Lu & Morimoto., 2009), or the strength of evidence that the effects 
observed were due to alcohol consumption (e.g. increased DNA adduction) was 
weakened by use of relatively unreliable estimates of exposure (questionnaire) 
and/or lack of consideration of potential confounders (Balbo et al., 2008).  
 
25. Members considered the reported evidence of chromosomal damage and MN 
induction across studies. Evidence for increased levels of MN in binucleated 
peripheral blood lymphocytes of clinically diagnosed alcoholic subjects was limited 
either by the small size of the studies,  high control MN frequencies (Maffei et al., 
2000; 2002) or the lack of account of smoking differences between subjects, in 
addition to other factors already discussed (Ramirez & Saldanha., 2002). Members 
cautioned that the evaluation of binucleate MN was a complicating factor as MN in 
binucleated cells could arise as a result of ex-vivo formation (Arsoy et al 2009). 
Furthermore, only two of the eight studies reporting on MN induction provided data 
on the range of background levels of MN in controls; most reported only mean and 
standard deviation. The Committee recalled that background levels of MN and 
chromosomal aberrations in human peripheral blood lymphocytes were previously 
considered by COM (with respect to pesticide exposure) when it was concluded that 
the large variability in background levels complicates interpretation of human 
genotoxicity studies (Battershill et al 2008).  
 
26. The Committee noted that several recent studies on the mutagenicity of 
alcoholic beverages had evaluated the influence of genetic polymorphisms in alcohol 
and aldehyde dehydrogenases (ADH, ALDH1) and P450 2E1 (CYP2E1), all in 
Japanese subjects.  It was agreed that data in ALDH2-deficient individuals (at least 
one ALDH2*2 allele confers slow activity) was particularly noteworthy, with two 
studies showing evidence of higher adduct levels and MN in individuals bearing the 
ALDH2-deficient allele. A single study, of hospitalised alcoholics, assessed alcohol 
exposure using both a questionnaire and measurement of alcohol concentrations in 
the blood and saliva (Yukawa et al., 2012). The average alcohol intake measured 
over a 24h period was 100ml ethanol (equivalent to 80 g/day). Levels of N2-ethyl-dG 
adduct were highest in subjects with the ALDH2*2 allele who were also hetero- or 
homozygotic for ADH1B*2 allele (confers faster activity) compared with wild-type. 
Elevated levels of N2-ethyl-dG and α-Me-γ-OH-PdG DNA adducts were also 
detected in a similar cohort of Japanese patients who reported consuming an 
average of 105 grams alcohol per day in the year proceeding admission (Matsuda et 
al., 2006). However, both these studies were relatively small in size and did not 
account for the nutritional status of individuals. Deficiency in micronutrients i.e. key 
vitamins and minerals such as selenium, vitamin E, folate and impaired glutathione 
levels are common in heavy drinkers, and can lead to impairment of DNA defence 
mechanisms and thus higher levels of genotoxicity.  
 
27. The remaining studies on polymorphisms based their exposure assessment 
either solely on self-completed questionnaires (Ishikawa et al., 2003; 2006; 2007; Lu 
& Morimoto., 2009; Wu et al., 2010) or provided no details on the exposure method 
used (Weng et al 2010). Higher levels of MN or DSBs in ALDH2-deficient subjects 
were detected, although the robustness of the data reported in three studies was 
weakened by the use of drinking frequency and not alcohol intake as the exposure 
metric (Ishikawa et al., 2006; Weng et al., 2010; Wu et al., 2010). One study that 
accounted for both BMI and nutrition observed a negative association between DSBs 
and drinking frequency in ALDH2-deficient subjects (Lu & Morimoto., 2009).  
 
28. Data from studies looking at combinations of ADH and ALDH polymorphisms 
were inconsistent.  Several studies reported increased genotoxicity when the 
ALDH2*2 allele was associated with the ADH1B*2 allele (conferring faster ADH 
activity – Weng et al., 2010; Wu et al., 2010); whilst Ishikawa et al (2007) observed 
increased genotoxicity when the ALDH2*2 allele was associated with the 
ADH1B*1/*1 or ADH1B*1/*2 genotypes (conferring slower activity – Ishikawa et al., 
2007).   
 
29. Overall, Members concluded that most of the studies investigating 
genotoxicity of alcoholic beverage consumption did not account for the confounding 
effects of BMI, or nutritional intake. Members also considered that other quality 
issues limited the reliability of the study findings e.g. use of small sample sizes, and 
poor exposure assessments based solely on self-completed or interview-led 
                                                          
1
 Polymorphisms in ADH1B include  alleles (variants)  that code for isozymes that show a faster rate 
of alcohol metabolism, while the ALDH2*2 allele results in a “deficient” form of ALDH2 
that causes an accumulation of acetaldehyde and its associated physiological effects. 
questionnaires. A handful of studies did not assess alcohol intake or account for 
smoking as a confounding exposure.  
 
30. In view of these limitations, the Committee updates its previous conclusion on 
the genotoxicity of alcoholic beverages to acknowledge the emergence of additional 
studies on DNA adduct formation in humans, and studies reporting the influence of 
polymorphisms in enzymes involved in alcohol metabolism, particularly in relation to 
induction of MN. However, the poor quality of most of these studies prevents any 
useful conclusions from being drawn. 
 
 
Hypotheses for the role of reactive oxygen species in the genotoxicity and 
mutagenicity of alcohol  
 
31. The Committee considered a paper reviewing the hypothesis that associates 
alcohol induced liver disease and carcinogenesis with the generation of reactive 
oxygen species (ROS) and the role of CYP2E1 in this process [MUT/2015/02].  
Whilst it was noted that the hypotheses were based on circumstantial associations 
generated principally from one group of researchers (Seitz and Stickel 2006, 2007, 
Wang et al 2009, Linhart et al 2014), Members agreed that there was sufficient 
evidence to support the hypotheses.   
 
32. Alcohol consumption can result in the formation of reactive oxygen species 
either via inflammatory mediated processes or oxidative metabolism. Reactive 
oxygen species have the potential to generate lipid peroxidation products which in 
turn may yield mutagenic, exocyclic DNA adducts.   
33. Ethanol consumption also results in the induction of CYP2E1, primarily in the 
liver, but also in certain extra-hepatic tissues such as the oesophagus and intestine.  
It is suggested that this induction enhances the metabolism of alcohol to 
acetaldehyde, the generation of ROS and accordingly the associated hazard of 
adduct formation.  A correlation between CYP2E1 levels and DNA etheno adducts 
has been demonstrated in animal models and in humans. However an association 
between specific CYP2E1 polymorphisms and alcoholic liver damage or alcohol-
induced carcinogenesis is not well defined.  
34. Overall Members considered the hypothesis that alcohol-induced oxidative 
stress is of importance in the pathogenesis of alcohol-induced liver injury, including 
carcinogenesis, to be plausible and that there was evidence to support them. 
However, more work would be required in this complicated area before definitive 
conclusions could be drawn.  
 
 
Hypothesis for the role of other metabolites in the genotoxicity and 
mutagenicity of alcohol  
 
35. Members reviewed the recent publication by Mitchell et al (2014), which 
provided confirmation that ethyl sulfate is a metabolite of ethanol. The 
physicochemical properties of ethyl sulfate suggest an ability to alkylate biological 
macromolecules. The authors noted that in chronic alcoholism, ethyl sulfate would 
be continually available via Phase II sulfonation. The authors cautioned that further 
research was necessary to delineate the metabolic fate of this compound and the 
extent to which the reaction occurs in vivo.   
 
36. Members agreed that these findings were of interest, but required biological 
evidence of the chemical reactivity of ethyl sulfate and its ability to form DNA adducts 
in vivo. Members expressed concern about the difficulties of studying this in vitro, 
namely the absence of sulfonation metabolism in available cell models and the 
difficulty in testing exogenously applied sulfate compounds, which do not readily 
pass through cell membranes. Potential experimental strategies to overcome these 
issues would be possible and include use of sulfotransferase knock-out and knock-in 
cells.  
 
 
Overall Conclusion  
 
37. The Committee agreed that the conclusions reached in 2000 would need 
updating in view of the additional studies investigating the mutagenic and genotoxic 
potential of ethanol, acetaldehyde and consumption of alcoholic beverages in 
humans. The following overall conclusions were agreed:  
 
a. The Committee concluded that acetaldehyde remains the metabolite of most 
concern with respect to the genotoxic effects of alcohol. 
 
b. The Committee noted that a number of studies have implicated the formation 
of acetaldehyde-specific DNA adducts and interstrand DNA crosslinks as 
upstream events in the genotoxicity of alcohol. However, the poor reliability of 
data available from studies on the genotoxicity of ethanol and alcoholic 
beverages (the latter being subject to a number of potentially confounding 
factors) in humans prevent the Committee from drawing any clear conclusions 
on the genotoxicity of alcohol per se. 
 
c. The Committee concluded that studies investigating genetic polymorphisms in 
key enzymes involved in ethanol metabolism suggest that the ALDH2-
deficient alleles are likely to contribute to the overall mutagenic and genotoxic 
potential of alcohol. At present data are inconsistent or lacking for genetic 
polymorphisms of other enzymes in this respect.  
 
d. The existing evidence is insufficient to support the suggestion that MN 
induced by ethanol occur via an aneugenic mechanism and by acetaldehyde 
via a clastogenic mechanism. Data suggest that multiple modes of action 
contribute to the overall genotoxicity.  
 
e. There is currently emerging, but limited evidence to support the proposal that 
acetaldehyde induces micronuclei via formation of replication-associated 
double stranded breaks in dividing cells. However, the Committee 
acknowledges the plausibility of this hypothesis.   
 
f. Further research is needed to determine whether the recently identified 
metabolite of ethanol, ethyl sulfate, contributes to the genotoxicity of ethanol 
and of alcoholic beverages.  
 
g. The Committee concluded that oxidative damage may also be an important 
mechanism of concern in the genotoxicity of alcohol. Studies on the capacity 
of target cells/tissues to metabolise ethanol via CYP2E1 and also 
consideration of the role of ADH in producing reactive oxygen species would 
further aid understanding of the role played by oxidative damage to DNA.  
 
 
COM 
July 2015  
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